A transparent bandage that doesn't restrict movement changes the entire workflow.
At the intersection of materials science and surgical care, a phosphorescent liquid bandage has quietly passed a threshold that matters: it can tell a surgeon whether transplanted tissue is alive with oxygen or quietly dying, without wires, obstruction, or interference. Tested on five patients undergoing breast reconstruction at two Boston hospitals, the paint-on sensor matched the accuracy of the standard wired oximeter while leaving the surgical field unencumbered. Developed with military funding to protect soldiers from the devastation of failed tissue transplants, the technology now stands at the edge of broader clinical life — a small glowing patch that may one day stand watch over wounds, burns, and failing limbs across medicine.
- Up to 5% of free-flap surgeries fail within 48 hours when blood flow falters, leaving patients facing repeat operations and prolonged suffering — a failure rate this technology was built to confront.
- The current standard, a wired oximeter, restricts patient movement, blocks the surgeon's view, and can produce false readings — practical flaws that erode its reliability in the critical post-operative window.
- The liquid bandage, painted directly onto transplanted tissue, fluoresces from red to green under a camera flash, offering a direct, wireless, real-time read of whether oxygen is reaching the graft.
- In a trial spanning seven transplanted flaps across five patients, the bandage matched the wired device's accuracy while all seven transplants succeeded — a proof of concept that clears the path to larger trials.
- Researchers have already developed a battery-powered, camera-free sensor version, and are now designing trials to test whether the bandage can catch a failing transplant before it is lost.
- The technology's horizon stretches well beyond reconstruction surgery — burn care, wound healing, peripheral artery disease, and trauma medicine all represent fields where continuous, non-invasive oxygen monitoring could reshape outcomes.
A paint-on bandage that shifts color from red to green depending on tissue oxygen levels has cleared its first human trial, offering surgeons a wireless, unobtrusive alternative to the cumbersome wired monitors that currently guard transplanted tissue in the critical hours after surgery.
Researchers at Massachusetts General Hospital and Beth Israel Deaconess Medical Center applied the phosphorescent liquid bandage to seven transplanted flaps in five women undergoing breast reconstruction. For 48 hours, they compared its readings against a standard wired oximeter. The results, published in Science Advances, confirmed the bandage performed with equivalent accuracy — but with none of the drawbacks. The wired device restricts movement, obstructs the surgeon's view, and can misread depending on lighting or patient position. The liquid bandage, once painted on, stays in place and reveals itself only when a camera flash excites its phosphorescent material into a telling glow.
The stakes are real. In free-flap surgeries — where tissue, fat, and blood vessels are harvested from one part of the body and microsurgically reattached elsewhere — failure rates reach 5 percent, most occurring within the first 48 hours when disrupted blood flow starves the graft of oxygen. The Department of Defense, motivated by the toll of such failures on combat-injured soldiers, funded the underlying technology through its Military Medical Photonics Program.
The current prototype still requires a camera with custom filters to interpret the bandage's glow, but the team has already developed a battery-powered, self-contained sensor that removes this dependency. The next step is a clinical trial designed to test whether the bandage can detect a transplant actively failing from oxygen deprivation — the scenario surgeons most urgently need to identify.
What began as a military initiative may ultimately find its widest use in civilian medicine: wound care, burn treatment, skin grafts, trauma surgery, and chronic vascular disease all represent fields where continuous, non-invasive oxygen monitoring could change outcomes. For now, the bandage has demonstrated the essential thing — that it can watch over transplanted tissue, quietly and accurately, without getting in the surgeon's way.
A paint-on bandage that glows red to green depending on how much oxygen is reaching transplanted tissue has passed its first test in human patients. Researchers at Massachusetts General Hospital and Beth Israel Deaconess Medical Center enrolled five women undergoing breast reconstruction surgery and applied the liquid bandage—made with phosphorescent materials—directly to seven transplanted flaps. For 48 hours after surgery, they monitored how well the bandage tracked tissue oxygenation and compared its readings to a wired oximeter, the current standard device used in operating rooms.
The results, published in Science Advances, showed the transparent bandage performed as accurately as the traditional monitor. But the implications go beyond matching a number on a screen. The wired oximeter is cumbersome. It restricts movement, obstructs the surgeon's view of the transplanted tissue, and can produce false readings depending on lighting or how the patient shifts in bed. The liquid bandage does none of these things. Once painted on, it stays in place, invisible except when a camera flash excites the phosphorescent material and causes it to fluoresce. The color change—from red in low-oxygen conditions to green in high-oxygen conditions—tells the story of whether the transplant is getting adequate blood flow.
The stakes for this technology are high. In free-flap surgeries, where surgeons harvest skin, fat, and blood vessels from one part of the body and microsurgically reattach them elsewhere, failure rates reach 5 percent. Most failures happen within the first 48 hours, when a disruption in blood flow can starve the transplanted tissue of oxygen. When that happens, the entire procedure fails, and the patient faces another surgery and a longer recovery. For soldiers injured in combat, the military's interest in this work stems from a desire to reduce exactly these kinds of devastating outcomes. The Department of Defense funded the underlying technology through its Military Medical Photonics Program.
The trial itself was straightforward in design but meticulous in execution. Between March and September 2017, the five women had the liquid bandage applied to a one-centimeter-by-one-centimeter area on each flap. The wired oximeter went on simultaneously. Both devices monitored tissue oxygenation continuously for two days. The bandage measures oxygen directly in the tissue itself, while the wired device uses near-infrared spectroscopy to infer oxygen saturation in the blood—a less direct measurement of the crucial blood flow that keeps a transplant alive. In all seven flaps, the bandage's readings tracked with the oximeter's, and all seven transplants succeeded.
The current prototype still requires a camera with custom filters to read the bandage. A clinician-researcher would photograph the glowing material after surgery, and the color shift would be recorded and analyzed. But the team has already moved beyond this limitation. They have developed a battery-powered sensor head that eliminates the need for the camera, making the bandage self-contained and truly wireless. This prototype was published separately in Biomedical Optics Express. The next phase is a clinical trial designed specifically to test whether the bandage can detect a transplant that is failing from oxygen deprivation—the real-world scenario surgeons need to identify quickly.
The potential applications extend far beyond breast reconstruction. Wound healing, skin grafts for burn victims, tissue transplants for trauma patients, and limbs affected by peripheral artery disease could all benefit from continuous, non-invasive oxygen monitoring. The technology might even detect early warning signs in patients with heart disease or other chronic conditions where reduced blood flow is a concern. What began as a military research initiative to save soldiers' limbs may end up reshaping how surgeons and physicians monitor tissue health across dozens of clinical scenarios. For now, the bandage has proven it can do what it was designed to do: tell a surgeon, in real time and without getting in the way, whether a transplanted piece of tissue is getting enough oxygen to survive.
Citas Notables
The standalone bandage is a major advancement from a wired oximeter that restricts a patient's movements and is complicated to use.— Conor L. Evans, PhD, senior author and principal investigator at MGH's Wellman Center for Photomedicine
The ability to have a wireless oxygen monitoring device for blood flow is potentially a gamechanger.— Samuel J. Lin, MD, MBA, plastic and reconstructive surgeon at BIDMC
La Conversación del Hearth Otra perspectiva de la historia
Why does a wired oximeter fail so often in the operating room if it's the standard tool?
It's not that it fails to measure—it's that it creates problems while measuring. The device restricts how the patient can move, it blocks the surgeon's view of the actual tissue, and the readings can shift based on room lighting or patient movement. You're trying to monitor something delicate while the tool itself gets in the way.
So the bandage is just more convenient, or is there something fundamentally better about how it measures?
Both. It measures oxygen directly in the tissue rather than inferring it from blood saturation, which is more precise. But yes, the convenience matters enormously in surgery. A surgeon needs to see what's happening and act fast if something goes wrong. A transparent bandage that doesn't restrict movement changes the entire workflow.
The trial only involved five women. How confident should we be in these results?
It's a validation study, not a definitive proof. The point was to show the bandage works in a human body under real surgical conditions. All seven flaps succeeded and the readings matched the standard device. That's enough to justify moving to the next phase—testing whether it can actually detect a failing transplant, which is the critical question.
Why did the military fund this if it's being tested on breast reconstruction?
Breast reconstruction is a free-flap surgery, the same microsurgical technique used to repair combat injuries. The military wanted to reduce transplant failure rates in wounded soldiers. Testing it in a civilian setting with good outcomes and willing patients made sense before moving to more complex trauma cases.
What happens next?
They're designing a trial to see if the bandage can actually catch a transplant in trouble. They've also built a battery-powered sensor so you don't need a camera anymore. Once that's validated, the applications expand—burns, trauma, chronic vascular disease, maybe even early detection of heart disease progression.